Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,090 | 254 | 98.0% |
| Education | $85.00 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $691.22 | 61 | $0 (2024) |
| Amgen Inc. | $422.67 | 25 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $309.66 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $244.99 | 15 | $0 (2024) |
| Daiichi Sankyo Inc. | $216.11 | 12 | $0 (2023) |
| ITI, Inc. | $192.17 | 8 | $0 (2023) |
| Lilly USA, LLC | $168.02 | 10 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $149.31 | 9 | $0 (2023) |
| Vifor Pharma, Inc. | $133.33 | 8 | $0 (2023) |
| Novo Nordisk Inc | $132.07 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $497.18 | 26 | ABBVIE INC. ($104.26) |
| 2023 | $1,439 | 78 | ABBVIE INC. ($272.70) |
| 2022 | $1,570 | 109 | ABBVIE INC. ($233.40) |
| 2021 | $667.84 | 42 | AbbVie Inc. ($80.86) |
All Payment Transactions
255 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/19/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: RETT SYNDROME | ||||||
| 04/15/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Endocrinology | ||||||
| 04/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Cardio-renal | ||||||
| 04/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: PSYCHIATRY | ||||||
| 04/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: PAIN | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Diabetes | ||||||
| 03/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Bone Health | ||||||
| 02/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: NEUROSCIENCE | ||||||
| 02/19/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: PSYCHIATRY | ||||||
| 02/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Inflammation | ||||||
| 02/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Oncology | ||||||
| 01/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: PAIN | ||||||
| 01/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: PAIN | ||||||
| 01/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: PSYCHIATRY | ||||||
| 01/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 310 | 379 | $38,876 | $15,334 |
| 2022 | 11 | 411 | 508 | $45,206 | $21,371 |
| 2021 | 8 | 188 | 200 | $22,132 | $11,311 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 85 | $15,045 | $5,815 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 93 | $11,625 | $4,476 | 38.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 25 | 25 | $5,000 | $2,534 | 50.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 15 | 15 | $1,935 | $812.50 | 42.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 55 | $2,310 | $473.59 | 20.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 24 | 24 | $744.00 | $341.04 | 45.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 24 | 24 | $720.00 | $341.04 | 47.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 14 | $752.00 | $267.41 | 35.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 18 | 21 | $630.00 | $248.64 | 39.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 23 | $115.00 | $24.89 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 150 | $21,484 | $10,345 | 48.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 63 | $7,121 | $3,571 | 50.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $5,874 | $3,462 | 58.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 32 | 32 | $4,128 | $1,698 | 41.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 46 | 79 | $3,318 | $663.28 | 20.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 32 | 32 | $992.00 | $472.14 | 47.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 13 | 13 | $611.00 | $451.13 | 73.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 29 | 29 | $870.00 | $420.60 | 48.3% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 16 | 19 | $570.00 | $235.51 | 41.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 18 | 32 | $160.00 | $39.38 | 24.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 12 | 26 | $78.00 | $11.63 | 14.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 86 | $12,298 | $6,804 | 55.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 17 | 17 | $3,106 | $1,825 | 58.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 20 | $2,240 | $1,048 | 46.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 17 | 17 | $2,193 | $933.87 | 42.6% |
About Emily Jones, NP
Emily Jones, NP is a Family healthcare provider based in Northport, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2017. The National Provider Identifier (NPI) number assigned to this provider is 1457870743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emily Jones, NP has received a total of $4,175 in payments from pharmaceutical and medical device companies, with $497.18 received in 2024. These payments were reported across 255 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,090).
As a Medicare-enrolled provider, Jones has provided services to 909 Medicare beneficiaries, totaling 1,087 services with total Medicare billing of $48,016. Data is available for 3 years (2021–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family Medicine
- Location Northport, AL
- Active Since 09/18/2017
- Last Updated 09/17/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1457870743
Products in Payments
- VRAYLAR (Drug) $312.63
- Kerendia (Drug) $309.66
- CAPLYTA (Drug) $242.03
- Otezla (Drug) $239.85
- REXULTI (Drug) $223.89
- UBRELVY (Drug) $220.80
- INJECTAFER (Drug) $216.11
- NURTEC ODT (Drug) $140.69
- MOUNJARO (Drug) $138.87
- Veltassa (Drug) $133.33
- XIFAXAN (Drug) $108.03
- Aimovig (Biological) $91.81
- Ozempic (Drug) $81.52
- QULIPTA (Drug) $81.14
- AUSTEDO (Drug) $77.93
- Dayvigo (Drug) $72.02
- Austedo XR (Drug) $71.38
- DAYBUE (Drug) $66.69
- ENTRESTO (Drug) $64.20
- ARISTADA (Drug) $57.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Northport
Mrs. Lauren Perkins, Crnp, CRNP
Family — Payments: $16,223
Staci Hardwick, Fnp-Bc, FNP-BC
Family — Payments: $9,103
Mary Jordan Armstrong
Family — Payments: $6,651
Shelby Warren, Np, NP
Family — Payments: $4,509
Karlie Ryan
Family — Payments: $3,782
Mrs. Mary Elizabeth Loomis, Np-C, NP-C
Family — Payments: $3,423